Related Experiment Videos
Differential oncogenic effects of methylnitrosourea
Journal of the National Cancer Institute
|January 1, 1975
Summary
Methylnitrosourea (MNU) oncogenic effects vary by dose and route. Different administration methods alter target organs and tumor types, indicating tissue susceptibility to MNU varies.
Area of Science:
- Toxicology
- Oncology
- Carcinogenesis
Background:
- Methylnitrosourea (MNU) is a known carcinogen.
- Understanding MNU's oncogenic effects is crucial for risk assessment.
Purpose of the Study:
- To investigate how varying dose schedules and administration routes of MNU influence its oncogenic effects.
- To identify target organs and tumor types induced by different MNU exposure conditions.
Main Methods:
- Rats were administered MNU via intravenous, oral, and injection routes with varied dose schedules.
- Tumor incidence, type, and survival times were recorded and analyzed.
Main Results:
- Intravenous MNU administration primarily targeted the nervous system, inducing neurogenic tumors.
- Alternative routes led to fewer neurogenic tumors but increased neoplasms at injection sites.
- Higher oral MNU doses reduced survival and neuroglial tumors but increased thymic lymphomas and nervous system mesenchymal tumors.
Conclusions:
- MNU exhibits oncogenic effects across multiple tissues.
- The specific dose, route, and schedule of MNU exposure significantly influence target organ specificity and tumor development.
- Neoplastic transformation by MNU is dependent on the degree of tissue exposure.